Upload File

ipa’s platinum jubilee celebrations launch program ipa … for papers new.pdf · þ biotechnology...

  • Home
  • Documents
  • IPA’s Platinum Jubilee Celebrations Launch Program IPA … for Papers NEW.pdf · þ Biotechnology and Biotherapeutics þ Pharmacology, Toxicology, Clinical Research and Pharmacovigilance
1
Last Date of Submission of Abstracts : 31 Jul 2014. The Scientific Services Committee has great pleasure in inviting you to submit findings of your original scientific work for presentation in any of the following scientific areas during the convention with the aim to disseminate knowledge and facilitate the exchange of new ideas among the members of pharmacy profession. þ Biopharmaceutics, Pharmacokinetics and Drug Metabolism þ Pharmaceutical Analysis and Quality Assurance þ Pharmacoeconomics and Pharmacoepidemiology þ Hospital, Community and Clinical Pharmacy þ Pharmaceutical Education & Professional Pharmacy þ Drug Regulatory Affairs þ Pharmaceutical Technology þ Medicinal Chemistry þ Pharmacognosy, Indigenous Drugs, Herbal Formulations and Phytochemistry þ Biotechnology and Biotherapeutics þ Pharmacology, Toxicology, Clinical Research and Pharmacovigilance þ Pharmaceutical Management The paper will be considered for presentation in poster session only. The abstract must be mailed to on or before 31 Jul 2014. For detailed information please visit www.ipapharma.org. No hard copies of abstracts will be entertained. [email protected] Contact for more details : IPA CONVENTION 2014 “Excellence in Quality - Applying Learnings to Practice” August 08, 2014. NIMHANS Convention Centre, Bangalore IPA’s Platinum Jubilee Celebrations Launch Program CALL FOR PRESENTATION OF PAPERS Guidelines for sending the abstract » Maximum words: 250 » Font type: Times New Roman. Font Size: 12. Line Spacing: 1.5. File Type: Microsoft Word. » No paragraph spacing or character spacing shall be entertained. » Language: English (UK) only - Spelling errors shall not be entertained by the Organizers. » Poster Board Size: 1 metre X 1 metre » The poster will be evaluated on your presentation skills, your innovativeness. » present Not more than 2 authors will be allowed in a poster. Only one author will be permitted to the poster. » disqualification The decisions of the Scientific Committee shall be final and no explanations or shall be given Mr. A.G. Raghu, Dr. Surendra Manek, Co-ordinators, Scientific Session, e-mail : [email protected]

Upload: phambao

Post on 15-Apr-2018

222 views

Category:

Documents


3 download

Report

TRANSCRIPT

Page 1: IPA’s Platinum Jubilee Celebrations Launch Program IPA … for Papers NEW.pdf · þ Biotechnology and Biotherapeutics þ Pharmacology, Toxicology, Clinical Research and Pharmacovigilance

Last Date of Submission of Abstracts : 31 Jul 2014.

The Scientific Services Committee has great pleasure in inviting you to submit findings of your original scientific work for presentation in any of the following scientific areas during the convention with the aim to disseminate knowledge and facilitate the exchange of new ideas among the members of pharmacy profession.

þ Biopharmaceutics, Pharmacokinetics and Drug Metabolism

þ Pharmaceutical Analysis and Quality Assurance þ Pharmacoeconomics and Pharmacoepidemiologyþ Hospital, Community and Clinical Pharmacy þ Pharmaceutical Education & Professional

Pharmacyþ Drug Regulatory Affairs

þ Pharmaceutical Technologyþ Medicinal Chemistryþ Pharmacognosy, Indigenous Drugs,

Herbal Formulations and Phytochemistryþ Biotechnology and Biotherapeuticsþ Pharmacology, Toxicology, Clinical

Research and Pharmacovigilanceþ Pharmaceutical Management

The paper will be considered for presentation in poster session only. The abstract must be mailed to on or before 31 Jul 2014. For detailed information please visit

www.ipapharma.org. No hard copies of abstracts will be entertained.

[email protected]

Contact for more details :

IPA CONVENTION 2014

“Excellence in Quality - Applying Learnings to Practice”

August 08, 2014. NIMHANS Convention Centre, Bangalore

IPA’s Platinum Jubilee Celebrations Launch Program

CALL FOR PRESENTATION OF PAPERS

Guidelines for sending the abstract

» Maximum words: 250

» Font type: Times New Roman. Font Size: 12. Line Spacing: 1.5. File Type: Microsoft Word.

» No paragraph spacing or character spacing shall be entertained.

» Language: English (UK) only - Spelling errors shall not be entertained by the Organizers.

» Poster Board Size: 1 metre X 1 metre

» The poster will be evaluated on your presentation skills, your innovativeness.

» present Not more than 2 authors will be allowed in a poster. Only one author will be permitted to the poster.

» disqualificationThe decisions of the Scientific Committee shall be final and no explanations or

shall be given

Mr. A.G. Raghu,Dr. Surendra Manek,

Co-ordinators, Scientific Session,e-mail : [email protected]

Glycosimilarity assessment of biotherapeutics 1

þ˚þˆþ”þØüÌþ“þí þ´þ×þ”þ·üÌþ“ -:þßþíþ“ · þflþóþ›þ”þäþÌþª þŁþ”þ˜þ˜ü— þŁþ”þìþ þ“þîþßþ“þí þŁþ”þ˜þ˜þ¤üÌþ“

Evaluation of Immunogenicity in Biotherapeutics

Review Article Immunogenicity of Biotherapeutics: Causes

Biotherapeutics as alternatives to antibiotics: … · Biotherapeutics as alternatives to antibiotics: Effects of IFN ... • Adenovirus vector ... •Porcine reproductive and respiratory

µ! |! Î! |! Ó! ¨! ¨! ½! ) Ý s T Ä*! õ Ý s 4 < p ¤ 4 Ä þ þ þ þ þ þ þ þ þ þ þ þ þ!193~194 õ Ý s < p f ¤ 4 Ä þ þ þ þ þ þ þ þ þ þ þ þ þ!195~198

New biotherapeutics: next-generation probiotics

Bioanalysis of Intact Biotherapeutics by Hybrid LBA/LCMS

Eleven BioTherapeutics

ARCUTIS BIOTHERAPEUTICS, INC

EYE ON ALLERGY - MedEdicus€¦ · Bausch + Lomb Incorporated; and Eleven Biotherapeutics; Contracted Research: Bausch + Lomb Incorporated; Eleven Biotherapeutics; and Rutech; OwnershipInterest:

archive.org ul...‹³³þ³þ³þ³þ³þþ׳³þþ r³þÛ³þÖ] öè³³þ³þ³þ³þ³þ³þ³þþÛ³þ×Ò ³³³³³³³³³³³³³³³³³³³³³³³³

CITY OF PHOENIX GENERAL PLANJan 12, 2021  · n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Þ n Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ

ADVANCE YOUR CONFIDENCE FOR BIOTHERAPEUTICS...2016/08/01  · ADVANCE YOUR CONFIDENCE FOR BIOTHERAPEUTICS. Agilent AdvanceBio Desalting-RP cartridges. • Perform MS detection with

Usp biotherapeutics - biological medicines

ATARA BIOTHERAPEUTICS, INC. - investors.atarabio.com · Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company that isdeveloping novel treatments

Vaxil BioTherapeutics Ltd

Kalon Biotherapeutics Agreement

Bridge Biotherapeutics, Inc Corporate Slides

ONCOLYTIC VIRUSES BIOTHERAPEUTICS AGAINST CANCER

TRIM: PATH3311 Biotherapeutics and Regenerative Medicine ... · PATH3311 Biotherapeutics and Regenerative Medicine TRIM: F31940 ... cell therapy and gene therapy; ... the mechanisms

þ`þ”þ™þçþ÷þ“ þ‘þfiþÌþßþ“ þ“þŁþ¸ þðþØþôþ ... · 2012-03-16 · 1 þ`þ”þ™þçþ÷þ“ þ‘þfiþÌþßþ“ þ“þŁþ¸ þðþØþôþ‡þîüÌþ“

eleven biotherapeutics, inc. form 10-q

R2 - comune.pegognaga.mn.it€¦ · Þ Þ Þ Þ Þ Þ Þ Þ Þ Þ

CALAVERAS COUNTY - ireb.net · ·|þ} ·|}þ ·|}þ ·|}þ ·|þ} ·|}þ ·|}þ ·|þ} ·|þ} ·|þ} ·|þ} ·|}þ ·|}þ ·|}þ ·|}þ ·|}þ r a i l r o a d f l a t r d d n r a

Cancer Biotherapeutics London

PROTALIX BIOTHERAPEUTICS

ATARA BIOTHERAPEUTICS, INC. · Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company that isdeveloping novel treatments for patients withcancer,

아그리즈 : 세계 최대 농기계 시장 · 2016. 4. 10. · 4GHI4 NK8^ Þ Þ _- Þ :`a VW Þ Þ Þ :`a [ VW Þ Þ Þ :`a [ Þ Þ Þ bc Þ Þ Þ Þ :`a VW Þ Þ Þ :`a [ Þ Þ

The Development of Live Biotherapeutics

c þ þ > 9 þ ?þ - Hþ Sþ þ þ Wl þ l þ · þ > 9 þ _ ?þ - Hþ Sþ þ þ Wl þ l þ _( i» Z¤j AÄ iöÄ » ¤'Ä ]( ¦ ¬ !2 Ä $:¡ 0gCW0g "² LG LG47.i L \ ê"Ü \6 ê6

Marinette County, Wisconsin...þ þ þ þ þ þ þ þ þ þ þ þþ þ þ þ þ þ þ þ þ þ þ þ þ þ þþ þ þ þ þ þ þ þ þ þ þþ þþ þ þ þ þ þ þ þ þ þ þ þ

 · × Ù × Ù Þ Õ Þ Õ Þ Õ þ × Ù þ Þ Õ Þ Õ

1ûþH7þ þòþÓ þ ûþþ³þ³$þãþß' þ þãþÛHþ£þß' 1H/ þ …þºþ¨þàþã. þ þ þ þ×þ®þß' þ þ þôüÍ þ þØþÓh þðþ¤þ 'þ®þß' aþ®þ¼üÌ

Editor’s ViEwpoint · financing of Eleven Biotherapeutics, a US-based biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics